Table 1

Demographic characteristics of study patients and the propensity score-matched sample by medicine use

Beta-blocker or combination drug use
No
(n=6168)
Yes
(n=6168)
n%n%
Age, median (IQR)60.6 (47.7–71.4)60.5 (47.7–70.4)
Stratify age
 20–49177228.7181229.4
 50–64192831.3194931.6
 65+246840240739
Gender
 Women311250.5313550.8
 Men305649.6303349.2
Comorbidity
 Hypertension324052.5305849.6
 Hyperlipidaemia231337.5220735.8
 Diabetes mellitus145223.5136322.1
 COPD103816.8101316.4
 Asthma5889.535619.1
 CKD5358.674937.99
 History of pneumonia2063.342043.31
 History of acute respiratory failure380.62410.66
 History of coronary artery disease164226.6158825.8
 History of stroke4747.684266.91
Other glaucoma medications
 PGA4216.835048.17
 CAI3665.934126.68
 Alpha agonist5759.325939.61
 Pilocarpine90914.781813.3
  • CAI, carbonic anhydrase inhibitor; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; PGA, prostaglandin analogue.